Low-level laser therapy: an adjunct therapy for the treatment of breast cancer related arm lymphoedema

File Size Format
68414_1.pdf 941Kb Adobe PDF View
Title Low-level laser therapy: an adjunct therapy for the treatment of breast cancer related arm lymphoedema
Author Box, RC; Barram, J; Chiwenga, L; Lloyd, D; Laakso, Liisa
Publication Title 8th Australasian Lymphology Association Conference: Reflections of the past, Inspirations for the future
Year Published 2010
Place of publication Melbourne
Publisher 8th Australasian Lymphology Association
Abstract Objective: To determine parameters of low-level laser therapy (LLLT) which provide clinically significant changes in breast cancer related lymphoedema (BCRL). Method: An audit of 22 women with BCRL treated with LLLT as an adjunct to conservative treatment within a private physiotherapy clinic setting. Characteristics of BCRL were a clinical presentation of soft pitting oedema in the medial aspect of the forearm, with palpable fibrotic/thickening changes. Mean age was 60.1 years (+13.78) with onset of BCRL at 1.93 years (+ 3.95) and a mean duration of 3.29 years (+ 3.14). The Riancorp LTU-904 provided an average LLLT dose of 4.42J (+ 0.81J) with manual lymphatic drainage treatment which may have included compression therapy between sessions. Results: During LLLT treatment, clinical changes in lymphoedema presentation were reflected by significant changes in the Miller Palpation rating of oedema (p<0.5). Other measures did not reach statistical significance but women reported reduction in the presence of ache, heaviness and tightness. Limb circumference and bioimpedance measurements did not change following treatment for the cohort overall but individual women had sustained changes over time. Correlations between dosage and clinical parameters were investigated to identify a clinical protocol for use in a randomized controlled study. Conclusions: LLLT may be a useful adjunct to conventional physiotherapy techniques for lymphoedema treatment in symptom reduction and softening of oedema. From the data collected, it is not clear if there is a specific set of parameters and dosage of LLLT which may provide objective improvement in BCRL.
Peer Reviewed No
Published Yes
Publisher URI http://lymphology.asn.au/new/documents/SE-03_Box.pdf
Copyright Statement Copyright remains with the authors 2010. The attached file is reproduced here in accordance with the copyright policy of the publisher. For information about this conference please refer to the conference's website or contact the authors.
Conference name 8th Australasian Lymphology Association Conference: Reflections of the past, Inspirations for the fu
Location Melbourne
Date From 2010-05-27
Date To 2010-05-29
URI http://hdl.handle.net/10072/38284
Date Accessioned 2011-02-14
Date Available 2011-09-08T06:58:28Z
Language en_AU
Research Centre Centre for Musculoskeletal Research; Griffith Health Institute
Faculty Griffith Health Faculty
Subject Complementary and Alternative Medicine
Publication Type Conference Publications (Extract Paper)
Publication Type Code e3

Brief Record

Griffith University copyright notice